semaglutide cvd and Cardiovascular Outcomes in Obesity without Diabetes Cardiovascular outcomes of semaglutide and

Untreated vitamin B12 deficiency may result in subacute combined degeneration of spinal cord or irreversible neuropathy, which may occur in the absence of megaloblastic anaemia

Although PIONEER 6 only showed an insignificant reduction of MACE, subcategory analysis demonstrated significant improvement in all-cause mortality [1.4% vs

Siamashvili M, Davis SN (2021) Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome

The PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways including variants in GLP1R and FTO genes that influence medication response intensity and side effect sensitivity